Zinc Finger 521 Modulates the Nrf2-Notch Signaling Pathway in Human Ovarian Carcinoma.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
29 Sep 2023
Historique:
received: 29 08 2023
revised: 21 09 2023
accepted: 27 09 2023
medline: 23 10 2023
pubmed: 14 10 2023
entrez: 14 10 2023
Statut: epublish

Résumé

The human zinc finger protein 521 (ZNF521) is a co-transcriptional factor with multiple recognized regulatory functions in a range of normal, cancer and stem cell compartments. ZNF521 regulates proliferation, progression and CSC (cancer stem cell) compartments in human ovarian cancer (hOC), which is a very aggressive and late-diagnosed female tumor. Two other important regulators of hOC are the NRF2 and NOTCH signaling pathways. In the present paper, the mRNA and protein levels of ZNF521 were correlated with those of the NRF2-NOTCH signaling components in two different hOC cell lines and in a public dataset of 381 hOC patients. The data show that high levels of ZNF521 significantly increase NRF2-NOTCH signaling expression; conversely, the silencing of ZNF521 impairs NRF2-NOTCH signaling. This experimental work shows that, in hOC, different levels of ZNF521 modulate the NRF2-NOTCH signaling pathway and also influences hOC CSC properties.

Identifiants

pubmed: 37834202
pii: ijms241914755
doi: 10.3390/ijms241914755
pmc: PMC10572470
pii:
doi:

Substances chimiques

NF-E2-Related Factor 2 0
Receptors, Notch 0
zinc finger protein 521, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

J Immunol Methods. 2009 Aug 15;347(1-2):70-8
pubmed: 19567251
Heliyon. 2020 Jun 05;6(6):e04020
pubmed: 32529062
PLoS Biol. 2012;10(11):e1001433
pubmed: 23209378
Front Mol Biosci. 2022 Apr 08;9:807324
pubmed: 35480877
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Neuron. 2011 Jan 27;69(2):215-30
pubmed: 21262462
Reproduction. 2017 Jun;153(6):R187-R204
pubmed: 28283672
Sci Rep. 2013;3:2084
pubmed: 23803955
Int J Mol Sci. 2021 Oct 06;22(19):
pubmed: 34639154
Int J Clin Exp Pathol. 2015 May 01;8(5):5642-9
pubmed: 26191276
Int J Mol Sci. 2021 Aug 06;22(16):
pubmed: 34445164
Cancer Sci. 2021 Feb;112(2):537-549
pubmed: 33185955
Int J Dev Biol. 2010;54(6-7):1175-88
pubmed: 20711994
Cancer Res. 2006 Feb 1;66(3):1517-25
pubmed: 16452208
Sci Signal. 2010 Jul 13;3(130):ra52
pubmed: 20628156
Nature. 2011 Feb 24;470(7335):503-9
pubmed: 21326203
Cancer Cell. 2018 Jul 9;34(1):21-43
pubmed: 29731393
Cell Death Dis. 2019 Sep 26;10(10):715
pubmed: 31558698
Ann N Y Acad Sci. 2010 Mar;1192:32-7
pubmed: 20392215
Free Radic Biol Med. 2015 Nov;88(Pt B):158-167
pubmed: 26003520
Cancers (Basel). 2020 Dec 26;13(1):
pubmed: 33375248
Cell Commun Signal. 2022 Jun 30;20(1):100
pubmed: 35773670
J Cell Sci. 2008 Oct 1;121(Pt 19):3109-19
pubmed: 18799787
Genes Dev. 2013 Oct 15;27(20):2179-91
pubmed: 24142871
Bone. 2009 Apr;44(4):528-36
pubmed: 19095088
PLoS One. 2022 Oct 3;17(10):e0274785
pubmed: 36191006
Kaohsiung J Med Sci. 2023 Mar;39(3):244-253
pubmed: 36397644
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7353-7362
pubmed: 30910979
Biochem J. 2007 Jun 1;404(2):289-98
pubmed: 17300219
Cell. 1991 Aug 23;66(4):649-61
pubmed: 1831692
Cell. 2017 Nov 30;171(6):1383-1396.e12
pubmed: 29195077
Int J Gynecol Cancer. 2015 Feb;25(2):208-13
pubmed: 25611897
Biochem Biophys Res Commun. 2020 Apr 16;524(4):895-902
pubmed: 32057361
Gynecol Oncol. 2010 Apr;117(1):130-3
pubmed: 20060575
Mol Cell Biol. 2014 Feb;34(4):653-63
pubmed: 24298019
J Clin Invest. 2014 Feb;124(2):730-41
pubmed: 24463449
Genes Cells. 2014 Mar;19(3):239-53
pubmed: 24580727
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22293-8
pubmed: 20007775
PLoS One. 2014 Mar 27;9(3):e92848
pubmed: 24676388
Oncol Lett. 2016 Oct;12(4):2686-2691
pubmed: 27698843
Cell. 2009 Apr 17;137(2):216-33
pubmed: 19379690
J Biol Chem. 2007 Apr 20;282(16):11969-81
pubmed: 17317671
Curr Top Dev Biol. 2010;92:165-200
pubmed: 20816395
Int J Mol Sci. 2023 Jan 03;24(1):
pubmed: 36614279
Bone. 2007 Feb;40(2):337-44
pubmed: 17029980
Blood. 2014 Apr 17;123(16):2451-9
pubmed: 24608975
Br J Cancer. 2005 Sep 19;93(6):709-18
pubmed: 16136053
J Biotechnol. 2015 May 20;202:12-30
pubmed: 25449014
Genes Cells. 2003 Apr;8(4):379-91
pubmed: 12653965
Mediators Inflamm. 2014;2014:318793
pubmed: 24976683
Cancer Res. 2005 Mar 15;65(6):2353-63
pubmed: 15781650
Cancer Cell Int. 2021 Feb 17;21(1):116
pubmed: 33596893
Stem Cell Investig. 2018 Mar 12;5:5
pubmed: 29682512
Biomed Res Int. 2020 Dec 10;2020:7594098
pubmed: 33381581
Onco Targets Ther. 2018 Nov 12;11:7979-7986
pubmed: 30519039
Curr Top Dev Biol. 2010;92:333-65
pubmed: 20816401
J Clin Med. 2020 Dec 26;10(1):
pubmed: 33375334
J Neurosci Res. 2002 Sep 15;69(6):745-9
pubmed: 12205667
Oxid Med Cell Longev. 2016;2016:7316492
pubmed: 27847554
J Hematol Oncol. 2023 May 2;16(1):45
pubmed: 37131214
Semin Cell Dev Biol. 2012 Jun;23(4):450-7
pubmed: 22306179
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15259-64
pubmed: 23986495
Nat Rev Mol Cell Biol. 2016 Nov;17(11):722-735
pubmed: 27507209
Med Oncol. 2010 Dec;27(4):1329-35
pubmed: 20012562
Cancer Biol Med. 2017 Feb;14(1):9-32
pubmed: 28443200
Acta Histochem. 2011 May;113(3):248-55
pubmed: 20122714
Oncol Rep. 2012 Jun;27(6):1918-24
pubmed: 22378150
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12250-12255
pubmed: 27791012
Front Oncol. 2022 May 17;12:811638
pubmed: 35656506
Mol Cells. 2023 Mar 31;46(3):153-164
pubmed: 36994474
Biomed Res Int. 2015;2015:165238
pubmed: 26788497
Physiol Rev. 2017 Oct 1;97(4):1235-1294
pubmed: 28794168
J Biol Chem. 2006 Jun 30;281(26):18015-24
pubmed: 16613847
Int J Mol Sci. 2020 Jul 06;21(13):
pubmed: 32640524
Cell. 2000 May 26;101(5):499-510
pubmed: 10850492
Stem Cell Res Ther. 2011 Apr 27;2(2):20
pubmed: 21539723
Oncotarget. 2017 May 16;8(20):32731-32740
pubmed: 28415574
Nat Cancer. 2021 Jan;2(1):6-8
pubmed: 35121897
Cancer Res. 2005 Sep 15;65(18):8530-7
pubmed: 16166334

Auteurs

Stefania Scicchitano (S)

Research Center of Biochemistry and Advanced Molecular Biology, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Maria Concetta Faniello (MC)

Research Center of Biochemistry and Advanced Molecular Biology, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.

Maria Mesuraca (M)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Department of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH